Normal blood coagulation is a complex process involving as many as 20 different proteins in blood plasma, which are known as blood coagulation factors.
Diagnostic to assess clotting disorders in surgery raises new capital A medical device company has raised nearly $1.3 million to advance a diagnostic to detect life-threatening bleeding and blood clots, according to a Form D filing with the U.S. Securities and Exchange Commission. HemoSonics‘ Point of Care Analyzer evaluates the systems that manage clotting: platelets, coagulation factors, fibrinogen and fibrinolytic proteins. The device is being [...]
June 11, 2013 - MedCity News
St Brendan in Market Wire (press release) Commenting on the agreement, Brendan Farrell, CEO of Trinity Biotech, said, "The addition of the ABI HPF4 product is a natural fit to our well established coagulation and point-of-care portfolio. We see great synergies for our sales and marketing...